{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04668898",
            "orgStudyIdInfo": {
                "id": "GCO 17-1846"
            },
            "secondaryIdInfos": [
                {
                    "id": "1U01NS107016-01A1",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1U01NS107016-01A1"
                }
            ],
            "organization": {
                "fullName": "Icahn School of Medicine at Mount Sinai",
                "class": "OTHER"
            },
            "briefTitle": "LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease",
            "officialTitle": "Dissecting Oligogenic Biomarkers in Ashkenazi Jews With Parkinson's Disease",
            "acronym": "BioPD",
            "therapeuticArea": [
                "Other",
                "Neurology"
            ],
            "study": "gba-and-other-genetic-biomarkers-in-eastern-european-ashkenazi-jews-with-and-without-parkinson-s-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-04-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-12-09",
            "studyFirstSubmitQcDate": "2020-12-09",
            "studyFirstPostDateStruct": {
                "date": "2020-12-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Rachel Saunders-Pullman",
                "investigatorTitle": "Professor, Neurology",
                "investigatorAffiliation": "Icahn School of Medicine at Mount Sinai"
            },
            "leadSponsor": {
                "name": "Icahn School of Medicine at Mount Sinai",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Massachusetts General Hospital",
                    "class": "OTHER"
                },
                {
                    "name": "National Institute of Neurological Disorders and Stroke (NINDS)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Single site observational study focused on elucidating the genes and biochemical pathways involved in causing Parkinson disease.",
            "detailedDescription": "This single site study, is enrolling Parkinson disease (PD) patients and their family members and is limited to participants of Ashkenazi (Eastern European) Jewish descent with GBA and LRRK2 mutations, or with 3 or more family members with PD. Follow-up will be for three years. Participants must be in the New York City area yearly and willing to come to Mount Sinai Downtown for yearly 2 hour study visits which include obtaining personal medical and family history information, blood, urine and spinal fluid samples, neurological exam and neuropsychiatric testing. De-identified data and samples will be securely stored at a central NIH-run repository for access by other researchers. Spinal fluid collection is encouraged but optional."
        },
        "conditionsModule": {
            "conditions": [
                "Parkinson Disease",
                "LRRK2",
                "GBA Gene Mutation"
            ],
            "keywords": [
                "Parkinson's disease",
                "Parkinsonian Disorders",
                "LRRK2",
                "GBA",
                "Movement Disorders",
                "Neurodegenerative Diseases"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "OTHER"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "The study team will be collecting DNA (ACD tubes), serum, plasma, RNA, peripheral blood monocytes, and urine. In a select group of patients, the study team will be collecting cerebrospinal fluid through a lumbar puncture. Samples are deposited in the Parkinson's Disease Biomarker Program repository."
            },
            "enrollmentInfo": {
                "count": 190,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LRRK2 Parkinson Disease",
                    "description": "Individuals with LRRK2-related Parkinson Disease"
                },
                {
                    "label": "GBA Parkinson Disease",
                    "description": "Individuals with GBA-related Parkinson Disease"
                },
                {
                    "label": "Idiopathic Parkinson Disease",
                    "description": "Individuals with Idiopathic (without any known genetic cause) Parkinson Disease"
                },
                {
                    "label": "LRRK2 non-manifesting carriers",
                    "description": "Individuals without Parkinson Disease who have a LRRK2 mutation"
                },
                {
                    "label": "GBA non-manifesting carriers",
                    "description": "Individuals without Parkinson Disease who have a GBA mutation"
                },
                {
                    "label": "Healthy control",
                    "description": "Individuals without a personal or family history (1st or 2nd degree) of a neurodegenerative disease"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Elucidate blood-based genetic biomarkers in Parkinson's disease",
                    "description": "Discovery and validation of new blood-based genetic biomarkers (both DNA and expression-based) for Parkinson's disease",
                    "timeFrame": "five years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Parkinson disease patients and their family members and is limited to participants of Ashkenazi (Eastern European) Jewish descent with GBA and LRRK2 mutations, or with 3 or more family members with PD\n* Participants must be local to the New York City area and willing to come to Mount Sinai Downtown for annual 2 hour study visits which include obtaining personal medical and family history information, blood, urine and spinal fluid samples, neurological exam and neuropsychiatric testing. Spinal fluid collection is encouraged but optional.\n\nExclusion Criteria:\n\n-Patients who do not have Parkinson disease or family members of Ashkenazi (Eastern European) Jewish descent who either has a GBA or LRRK2 mutations OR who has 3 or more family members with PD.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "30 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Parkinson disease patients and their family members who are of Ashkenazi (Eastern European) Jewish descent who either have a GBA or LRRK2 mutations or who have 3 or more family members with PD.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Maya Rawal, MS, CGC",
                    "role": "CONTACT",
                    "phone": "212-844-8373",
                    "email": "Maya.Rawal@mountsinai.org"
                },
                {
                    "name": "Deborah Raymond, MS",
                    "role": "CONTACT",
                    "phone": "212-844-8713",
                    "email": "deborah.raymond@mountsinai.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rachel Saunders-Pullman, MD, MPH",
                    "affiliation": "Icahn School of Medicine at Mount Sinai",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Laurie Ozelius, PhD",
                    "affiliation": "Massachusetts General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mount Sinai-- Downtown Union Square",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "11104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maya Rawal, MS, CGC",
                            "role": "CONTACT",
                            "phone": "212-844-8373",
                            "email": "Maya.Rawal@mountsinai.org"
                        },
                        {
                            "name": "Deborah Raymond, MS",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Rachel Saunders-Pullman, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).",
            "infoTypes": [
                "STUDY_PROTOCOL"
            ],
            "timeFrame": "Clinical data deposited in Parkinson Disease Biomarker Program DMR after study visit",
            "accessCriteria": "Investigators whose proposed use of the data has been approved by an independent review committee (\"learned intermediary\") identified for this purpose. The type of analysis will be for individual participant data meta-analysis. Data are available indefinitely at: https://pdbp-demo.cit.nih.gov/researchers."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010300",
                    "term": "Parkinson Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020734",
                    "term": "Parkinsonian Disorders"
                },
                {
                    "id": "D000001480",
                    "term": "Basal Ganglia Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000080874",
                    "term": "Synucleinopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13213",
                    "name": "Parkinson Disease",
                    "asFound": "Parkinson's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22494",
                    "name": "Parkinsonian Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M25603",
                    "name": "Ganglion Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M16358",
                    "name": "Synovial Cyst",
                    "relevance": "LOW"
                },
                {
                    "id": "M4774",
                    "name": "Basal Ganglia Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2217",
                    "name": "Synucleinopathies",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        }
    },
    "hasResults": false
}